Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer.
1 Division of Infectious Disease, University of Maryland Medical Center , Baltimore, Maryland.
Michelle
M
Doll
2 Greenbaum Cancer Center and Division of Infectious Disease, University of Maryland School of Medicine , Baltimore, Maryland.
Michael
M
Kleinberg
3 Department of Pathology, University of Maryland Medical Center , Baltimore, Maryland.
Dina
D
Kokh
4 Institute of Human Virology and Division of Infectious Disease, University of Maryland School of Medicine , Baltimore, Maryland.
David J
DJ
Riedel
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D002945:Cisplatin / Q000627:therapeutic use; D000068679:Emtricitabine / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000254:growth & development; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008875:Middle Aged; D010078:Oxazines; D000068437:Pemetrexed / Q000627:therapeutic use; D010879:Piperazines; D045363:Pneumocystis carinii / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000382:microbiology; D011728:Pyridones; D000068698:Tenofovir / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D019562:Viral Load / Q000187:drug effects; D000099226:Dolutegravir
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002945:Cisplatin; D000068679:Emtricitabine; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D000068437:Pemetrexed; D010879:Piperazines; D011728:Pyridones; D000068698:Tenofovir; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000099226:Dolutegravir